Edwards Lifesciences To Webcast Annual Meeting Of Stockholders
Get Alerts EW Hot Sheet
Join SI Premium – FREE
IRVINE, Calif., May 1, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will host its Annual Meeting of Stockholders on Wednesday, May 8, 2019 beginning at 10:00 a.m. PT (1:00 pm ET) at its corporate headquarters in Irvine, California.

A live webcast of the meeting will be available to all interested parties on the Edwards Lifesciences' investor relations website at http://ir.edwards.com. Following the meeting, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section. A live stream and archived replay can also be accessed via mobile devices by downloading Edwards' IR App for iPhone and iPad or Android.
About Edwards Lifesciences
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit www.Edwards.com and follow us on Twitter @EdwardsLifesci.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
View original content to download multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-webcast-annual-meeting-of-stockholders-300841643.html
SOURCE Edwards Lifesciences Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EVERSANA Expands AI-Powered Commercialization Platform with New Capabilities Across Medical Affairs, Market Research and Commercial Operations
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease
- PowerBank Receives Final Environmental Permit for C$14 Million Nova Scotia Community Solar Project, Backed by C$4.55 Million in Federal and Provincial Grants and Tax Credits
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share